• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

“BRAZEN AND SHOCKING:” GENIUS FUND CASE GETS UGLIER

By Alex Halperin
10/18/2020 08:39 PM GMT-0700
FacebookTweetPin

Following the dissolution of Genius Fund, a SoCal company that blew through $164M, the company’s former CEO is accusing individuals associated with the company of moving or selling more than $3M in assets in violation of a court order. Genius Fund representatives did not respond to a request for comment.
WeedWeek

  • Francis Racioppi Jr., who is suing the company, called the action a “brazen and shocking” move that represents a “direct affront” to the court’s authority.
  • Racioppi’s lawyer called his motion for contempt “an extraordinary legal remedy” justified by the “blatant violation of a federal court order.”
  • Genius Fund was backed by Russian oligarch Dmitry Bosov who was found dead of an apparent self-inflicted gun wound in May.

Separately, SoCal-based retailer MedMen ????saw its stock fall to 12 cents after reporting a 40% drop in sales from the previous quarter.
Business Insider

Share:
FacebookTweetPin
Filed Under:
Federal

Primary Sidebar

Upcoming Webinar

Growth in a Tight Market

WeedWeek Wonks: The Accounts Receivable Crisis

Duration May 14th @ 1pm EST
Speakers Adam Stettner, Brett Gelfand, Alex Halperin

RSVP NOW

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Federal Articles
280e
Federal

Trump reschedules MED, with mixed signals on 280E

Senate
Federal

Newsbrief: Rescheduling imminent, per Axios

pot lobbyists
Federal

Newsbrief: Anti-legalization activists sue feds over cannabis coverage

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved